Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Eugene
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Eugene, OR

Studies commonly pay $75 to $4,500 per completed study

144 clinical trials are currently recruiting participants within 30 miles of Eugene. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

144studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Eugene right now

Top 25 of 144 recruiting studies, sorted by proximity — each links to its official registry page

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center) — Eugene, Oregon (1.6 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06773910)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
Oncology Associates of Oregon PC — Eugene, Oregon (1.6 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06881784)

Walk With Me (WWM) for Perinatal Grief

Grief, Post Traumatic Stress Disorder N/A Interventional 300 participants sought
Oregon Research Behavioral Intervention Strategies, Inc. — Eugene, Oregon (1.6 mi) · Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07011940)

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

Essential Thrombocythemia Phase 3 Interventional 426 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07623200)

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 270 participants sought
517 — Eugene, Oregon (1.6 mi) · Sponsor: Corcept Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06906341)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222800)

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma (MM), Multiple Myeloma Refractory Phase 2 Interventional 46 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07637578)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Polycythemia Vera Phase 3 Interventional 220 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Italfarmaco
See eligibility & contact on ClinicalTrials.gov (NCT06093672)

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer Phase 3 Interventional 531 participants sought
Willamette Valley Cancer Institute and Research Center /ID# 280617 — Eugene, Oregon (1.6 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07365241)

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

Language Delay, Substance Use Disorders N/A Interventional 244 participants sought
Prevention Science Institute — Eugene, Oregon (1.6 mi) · Sponsor: University of Oregon
See eligibility & contact on ClinicalTrials.gov (NCT07529327)

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Urothelial Cancer, Urinary Bladder Neoplasms Phase 3 Interventional 390 participants sought
Williamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07566156)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostatic Neoplasms Phase 3 Interventional 1,203 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07164443)

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 850 participants sought
Oncology Associates Of Oregon, Pc — Eugene, Oregon (1.6 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361497)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2, Phase 3 Interventional 274 participants sought
Verum Research LLC — Eugene, Oregon (1.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Chronic Kidney Disease and Hypertension Phase 3 Interventional 5,000 participants sought
Research Site — Springfield, Oregon (4.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06742723)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Oncology Associates of Oregon, P.C. /ID# 275006 — Eugene, Oregon (1.6 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Non-Small Cell Lung Cancer Phase 3 Interventional 1,600 participants sought
Willamette Valley Cancer Institute and Research Center (WVCI) — Eugene, Oregon (1.6 mi) · Sponsor: Summit Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT05899608)

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS) Phase 3 Interventional 48 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi) · Sponsor: Institut de Recherches Internationales Servier
See eligibility & contact on ClinicalTrials.gov (NCT06465953)
Actively enrolling

Studies you may be able to join near Eugene

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Eugene

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Willamette Valley Cancer Institute and Research Center - Eugene

★ 4.2 (87 reviews)
520 Country Club Rd, Eugene, OR 97401
(541) 683-5001
"Dr's & nurses are great but they seem super disorganized! They keep changing my son's infusion times. Nobody has called about getting his port. Monda…"
— Jennifer Hernandez, 2★

University of Oregon Prevention Science Institute

University of Oregon, 1600 Millrace Dr, Eugene, OR 97403
(541) 346-3630

The Alliance for Community Wellness

★ 4.6
1195 City View St, Eugene, OR 97402
(541) 342-5394
"They came across to me like people who really care about other people.They listen to me and they've offered me help.I feel very blessed to have found…"
— Jared Watts, 5★

Robert and Beverly Lewis Integrative Science Building

★ 5.0
University of Oregon, Eugene, OR 97401

Benson Health Clinic

★ 3.2 (40 reviews)
66 Club Rd Ste 140, Eugene, OR 97401
(541) 345-1722
"I've worked with Dr. Lumos for a few years and have had great support in sessions! Kind, empathetic, and flexible. Solid front desk staff, though I'v…"
— Jade, 4★

OHSU Child Development and Rehabilitation Center, Eugene

★ 3.1
74 B Centennial Loop STE 100, Eugene, OR 97401
(503) 346-1640
"Been on a supposed waitlist for well over a year to get my son seen. They told my son’s doctor they called several times and I never answered. Though…"
— Mary Bates, 1★

Oregon Social Learning Center

★ 4.4
10 Shelton Mcmurphey Blvd, Eugene, OR 97401
(541) 485-2711

Willamette Valley Cancer Institute and Research Center - Springfield

★ 3.3 (3 reviews)
3355 Riverbend Dr #240, Springfield, OR 97477
(541) 683-5001
"The organization is lacking and has made me feel uncared for due to what seems to be a lack of accountability. Although I've received apologies, ther…"
— C M, 1★

Lewis Integrative Science Building

1440 Franklin Blvd, Eugene, OR 97403

Clinical trials in Eugene: what's recruiting

The Eugene area currently has 144 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Eugene, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Eugene, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Eugene

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Eugene participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Eugene?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Eugene safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Eugene?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Eugene?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Eugene.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Eugene typically complete one or two studies per year.

Paid clinical trials near Eugene

Other metros within reach

Salem, OR111 Portland, OR1,031 Vancouver, WA1,031 Medford, OR39 Olympia, WA229 Tacoma, WA1,454 Bremerton, WA1,475 Seattle, WA1,503

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Eugene Bladder Issues Due To Spinal Cord Injury in Eugene All conditions

More of OR

Portland1,031 Salem111 Medford39

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts